MPs/NPs diminish the tight junction proteins, decrease trans-epithelial resistance, and increase the expression of cellular matrix metallopeptidase 9 (MMP9), leading to lung injury and lowering the ability for lung repair, contributing to the pathogenesis of several lung diseases, such as asthma, COPD, and acute respiratory distress syndrome. This evidence concerns the gene MMP9 and lung disorder.